As widely expected, Nifty struggles for direction — a tug-of-war between the bulls and bears witnessed as both sides fought to make their mark — reflecting indecision and heightened volatility.
Nifty (-1, 25721)
Sensex (-61, 83878)
Bank Nifty (+232, 58008)
Nifty (CMP: 25721)
SUPPORT: 25579/25451
RESISTANCE: 25900/26107
TRADING RANGE (25650-26800)
BIAS: Neutral
SECTOR GAINER:
PSU BANKS (+2.17%)
NIFTY REALITY (+1.43%)
NIFTY OIL & GAS (+0.69%)
SECTOR LOSER:
NIFTY PCONSUMER (-0.81%)
NIFTY DIGITAL (-0.55%)
NIFTY IT (-0.53%)
STOCKS IN SPOTLIGHT:
1) Patanjali Foods (-4.57%) plunged posted a 67.4 percent year-on-year rise in standalone net profit to Rs 517 crore in Q2 FY26, marking its strongest quarter to date on turnover and profit metrics. Revenue rose 21 percent year-on-year to Rs 9,344.9 crore, while EBITDA increased 19.4 percent to Rs 552 crore. EBITDA margin stood at 5.6 percent, marginally lower than 5.7 percent a year earlier.
2) JK Cement (-3.67%) plunged as Q2 PAT halves QoQ to Rs 161 cr; EBITDA margin expands to 15.1%. The company reported a 50.52% tumble in consolidated net profit to Rs 160.53 crore on a 9.94% drop in revenue from operations to Rs 3,019.20 crore in Q2 FY26 as compared with Q1 FY26.
3) Medplus Health Services (+11.82) jumped out of the gate after the company reported a 43.3% jump in consolidated net profit to Rs 55.50 crore on 6.5% increase in revenue from operations to Rs 1,679.33 crore in Q2 FY26 over Q2 FY25.
4) Bank of Baroda (+4.29%) jumped after the bank reported a 8.2% decline in standalone net profit to Rs 4,809.39 crore on 1.2% decline in total income to Rs 35,025.76 crore in Q2 FY26 over Q2 FY25.
5) R R Kabel (+1.5%) climbed after the company’s consolidated net profit surged 133.1% to Rs 116.26 crore in Q2 FY26, compared with Rs 49.53 crore in Q2 FY25. Revenue from operations increased 19.5% YoY to Rs 2,163.77 crore in Q2 FY26.
KEY THEMES FOR THE DAY:
1) Sentiment still fragile at Dalal Street after Friday’s drubbing, the battle for directional clarity continues — and Nifty remains caught in a narrow range, wavering without conviction.
Caution is the buzzword!
2) The trading theme still revolves around FIIs selling in Friday’s trade. to the tune of ₹6,769 crore, triggering concerns over sustained pressure on Indian equities.
3) Key Q2 Earnings:
Monday (November 3rd): BHARTI AIRTEL, TITAN, POWERGRID, AMBUJA CEMENTS, TATA CONSUMER, AJANT PHARMA, JK PAPER
Tuesday (November 4th): SBI, M&M, ADANI PORTS, ADANI ENTERPRISES, INDIGO, INDIAN HOTELS, PAYTM, SUZLON ENERGY, ESCORTS, GRSE.
Wednesday (November 5th): SUN PHARMA, GRASIM, AUROBINDO PHARMA, BLUE STAR, DELHIVERY, PIRAMAL PHARMA, BEML.
Top Index Gainers:
SHRIRAMFIN (+5.35%)
M&M (+1.96%)
SBI (+1.32%)
INDIGO (+0.86%)
EICHER MOTORS (+0.66%)
Top Index Losers:
MARUTI (-3.3%)
BEL (-1.5%)
TITAN (-1.36%)
NESTLE INDIA (-0.87%)
TCS (-0.78%)
# 10:45 AM GLOBAL UPDATE:
Dow Futures: (+47, 47611)
Nasdaq 100 Futures (+103, 25961)
Nikkei (Closed, 52411)
Hang Seng (+169, 26076)
Dollar Index (-0.03%, 99.77)
WTI OIL (-0.74%, 60.13)
Gold (+5, 4008)
Securities in Ban for Trade Date: Monday, November 3rd 2025*
NIL
Disclaimer/ Disclosure: The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points does not construe investment advice as stock market investments are subject to market risks so please refer to your financial consultant advice before Investing or trading. All information is a point of view, and is for educational, Learning and informational use only. The author or the group admin accepts no liability for any interpretation of articles or comments on this platform being used for actual investments. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investors must make their own investment decisions based on their specific investment objectives, goals and financial position only after consulting with registered market intermediaries.